SK3242002A3 - Calcium complex of phosphorus containing ethylenediamine derivatives - Google Patents

Calcium complex of phosphorus containing ethylenediamine derivatives Download PDF

Info

Publication number
SK3242002A3
SK3242002A3 SK324-2002A SK3242002A SK3242002A3 SK 3242002 A3 SK3242002 A3 SK 3242002A3 SK 3242002 A SK3242002 A SK 3242002A SK 3242002 A3 SK3242002 A3 SK 3242002A3
Authority
SK
Slovakia
Prior art keywords
kappa
cap
carboxy
methyl
bis
Prior art date
Application number
SK324-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Johannes Platzek
Ulrich Niedballa
Gunter Michl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7922563&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK3242002(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE19944893A external-priority patent/DE19944893C2/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of SK3242002A3 publication Critical patent/SK3242002A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Detergent Compositions (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Cosmetics (AREA)
SK324-2002A 1999-09-09 2000-09-06 Calcium complex of phosphorus containing ethylenediamine derivatives SK3242002A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19944893A DE19944893C2 (de) 1999-09-09 1999-09-09 Calcium-Komplex von [[(4R)-4-[bis[(carboxy-.kappa.O)methyl]amino-. kappa.N]-6,9-bis[(carboxy-.kappa.O)methyl]-1-[(4,4-diphenylcyclohexyl)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-yl-säure-.kappa.N6, .kappa.N9,.kappa.O11]1-oxidato(6-)]-, hexahydrogen, dessen Salze und diese Komplexe enthaltende pharmazeutische Mittel
PCT/EP2000/008694 WO2001018011A1 (en) 1999-09-09 2000-09-06 Calcium complex of phosphorus containing ethylenediamine derivatives

Publications (1)

Publication Number Publication Date
SK3242002A3 true SK3242002A3 (en) 2002-10-08

Family

ID=7922563

Family Applications (1)

Application Number Title Priority Date Filing Date
SK324-2002A SK3242002A3 (en) 1999-09-09 2000-09-06 Calcium complex of phosphorus containing ethylenediamine derivatives

Country Status (29)

Country Link
EP (1) EP1210353B1 (sr)
JP (1) JP2003508537A (sr)
KR (1) KR100650090B1 (sr)
CN (1) CN100341883C (sr)
AT (1) ATE245159T1 (sr)
AU (1) AU783982B2 (sr)
BG (1) BG65280B1 (sr)
BR (1) BR0013871A (sr)
CA (1) CA2380766C (sr)
CZ (1) CZ2002834A3 (sr)
DE (2) DE19964224B4 (sr)
DK (1) DK1210353T3 (sr)
EE (1) EE05106B1 (sr)
ES (1) ES2202178T3 (sr)
HR (1) HRP20020302B1 (sr)
HU (1) HUP0202873A3 (sr)
IL (1) IL148563A (sr)
MX (1) MXPA02001583A (sr)
NO (1) NO20021167D0 (sr)
NZ (1) NZ517708A (sr)
PL (1) PL354749A1 (sr)
PT (1) PT1210353E (sr)
RS (1) RS50125B (sr)
RU (1) RU2247727C2 (sr)
SK (1) SK3242002A3 (sr)
TW (1) TWI263641B (sr)
UA (1) UA74165C2 (sr)
WO (1) WO2001018011A1 (sr)
ZA (1) ZA200202742B (sr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201514188A (zh) * 2013-03-13 2015-04-16 Lantheus Medical Imaging Inc 製備釓磷維塞三鈉單水合物之方法
CN114845990A (zh) 2019-12-20 2022-08-02 伯拉考成像股份公司 钙bopta配合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3129906C3 (de) * 1981-07-24 1996-12-19 Schering Ag Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik
TW319763B (sr) * 1995-02-01 1997-11-11 Epix Medical Inc
US5919967A (en) * 1997-04-11 1999-07-06 Epix Medical, Inc. Process for synthesizing phosphodiesters

Also Published As

Publication number Publication date
HUP0202873A3 (en) 2003-12-29
HK1050202A1 (zh) 2003-06-13
DE19964224A1 (de) 2001-06-28
WO2001018011A1 (en) 2001-03-15
CA2380766C (en) 2008-11-25
CN100341883C (zh) 2007-10-10
MXPA02001583A (es) 2004-04-05
EE200200090A (et) 2003-04-15
PL354749A1 (pl) 2004-02-23
DE60003931T2 (de) 2004-05-27
HRP20020302A2 (en) 2004-02-29
UA74165C2 (uk) 2005-11-15
IL148563A0 (en) 2002-09-12
CA2380766A1 (en) 2001-03-15
BG106488A (bg) 2002-10-31
KR20020025256A (ko) 2002-04-03
DE60003931D1 (de) 2003-08-21
IL148563A (en) 2005-12-18
CN1373765A (zh) 2002-10-09
ATE245159T1 (de) 2003-08-15
BR0013871A (pt) 2002-05-21
WO2001018011A9 (en) 2002-09-06
AU783982B2 (en) 2006-01-12
ZA200202742B (en) 2003-09-23
ES2202178T3 (es) 2004-04-01
RU2247727C2 (ru) 2005-03-10
YU16102A (sh) 2005-06-10
PT1210353E (pt) 2003-11-28
KR100650090B1 (ko) 2006-11-27
HRP20020302B1 (en) 2005-08-31
EP1210353B1 (en) 2003-07-16
JP2003508537A (ja) 2003-03-04
HUP0202873A2 (hu) 2002-12-28
NZ517708A (en) 2003-10-31
CZ2002834A3 (cs) 2002-07-17
TWI263641B (en) 2006-10-11
AU7774900A (en) 2001-04-10
DK1210353T3 (da) 2003-10-27
EP1210353A1 (en) 2002-06-05
RS50125B (sr) 2009-03-25
EE05106B1 (et) 2008-12-15
NO20021167L (no) 2002-03-08
DE19964224B4 (de) 2005-09-01
NO20021167D0 (no) 2002-03-08
BG65280B1 (bg) 2007-11-30

Similar Documents

Publication Publication Date Title
DE3401052C2 (de) Diagnostische Mittel
EP0485045B1 (de) Mono-N-substituierte 1,4,7,10-Tetraazacyclododecan-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
EP0405704B1 (de) Derivatisierte DTPA-Komplexe, diese Verbindungen enthaltende pharmazeutische Mittel, ihre Verwendung und Verfahren zu deren Herstellung
WO1997026017A2 (de) Perfluoralkylhaltige metallkomplexe und ihre verwendung in der nmr-diagnostik
DE3825040A1 (de) 5- oder 6-ring- enthaltende makrocyclische polyaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
DE60207288T2 (de) Gewebespezifische fluoreszierende chelate
EP3551614B1 (en) Dimeric contrast agents
EP0680464B1 (de) Derivatisierte dtpa-komplexe, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung als nmr- und röntgenkontrastmittel und verfahren zu deren herstellung
AU783982B2 (en) Calcium complex of phosphorus containing ethylenediamine derivatives
US6559330B1 (en) Calcium complex of [[(4r)-4-[bis{carboxy-.kappa.o)methyl]amino-.kappa.n]-6,9-bis[(carboxy.kappa.o)methyl]-1-[(4,4-diphenylcyclohexyl)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-ylic-acid-.kappa.n6,.kappa.n9,.kappa.011]1-oxidato(6-)]-, hexahydrogen, its salts, pharmaceutical agents that contain these complexes, their use in treatment and as additives in diagnosis, as well as processes for the production of the complexes and agents
EP1102770A1 (de) Paramagnetische 3-,8-substituierte deuteroporphyrinderivate, diese enthaltende pharmazeutische mittel, verfahren zu ihrer herstellung und ihre verwendung für das nekrose- und infarkt-mr-imaging
DE4340809A1 (de) 1.4,710-Tetraazacyclododecan-Derivate, deren Verwendung, diese enthaltende pharmazeutische Mittel und Verfahren zu deren Herstellung
US20030203879A1 (en) Calcium complex of [[(4R)-4-[bis[(carboxy-.kappa.O)methyl]amino-.kappa.n]-6,9-bis[(carboxy.kappa.O)methyl]-1-[(4,4-diphenylcyclohexy)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-ylic-acid-.kappa.N6,.Kappa.N9,.Kappa 011]1-oxidato(6-)]-, hexahydrogen, its salts, pharmaceutical agents that contain these complexes, their use in treatment and as additives in diagnosis, as well as processes for the production of the complexes and agents
DE4403039A1 (de) Oktaazamakrocyclen, deren Metallkomplexe, Verfahren zu deren Herstellung, diese Komplexe enthaltende Mittel sowie deren Verwendung in Diagnostik und Therapie
DE19944893C2 (de) Calcium-Komplex von [[(4R)-4-[bis[(carboxy-.kappa.O)methyl]amino-. kappa.N]-6,9-bis[(carboxy-.kappa.O)methyl]-1-[(4,4-diphenylcyclohexyl)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-yl-säure-.kappa.N6, .kappa.N9,.kappa.O11]1-oxidato(6-)]-, hexahydrogen, dessen Salze und diese Komplexe enthaltende pharmazeutische Mittel
DE19546234C1 (de) Neue makrobicyclische Verbindungen, Verfahren zu ihrer Herstellung und diese makrobicyclischen Verbindungen enthaltende pharmazeutische Mittel
PT1072604E (pt) Complexo de calcio do (4r)-4-bis(carboxi-kappa.o)metil amino-.kappa.n-6,9-bis(carboxy-.kappa.o)metil-1-(4,4-difenilciclo-hexil)oxi-1-hidroxi-2-oxa-6,9-diaza-1-fosfaundecan-11.oico-.kappa.n6,.kappa.n9,.kappa.o11 1-oxidato(6-)-,hexa-hidrogenado seus sais agentes farmaceuticos contendo estes complexos sua utilizacao terapeutica e como aditivos em agentes de diagnostico assim como um processo para a preparacao dos complexos e agentes
HK1002810B (en) Dtpa-complexes derivatives, pharmaceutical compositions containing them, their use and process for their preparation

Legal Events

Date Code Title Description
FC9A Refused patent application